All In Biotech

Drug Trial Radar · NCT06834789

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

A Phase 1 Study to Evaluate the Safety and Efficacy of Co-administration of AGN-151586 and BOTOX® in Subjects for Treatment of Glabellar Lines (GL)

Last checked: Nov 20, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

132

Actual

Start

Feb 18, 2025

Primary completion

Nov 3, 2025

Study completion Nov 3, 2025

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Feb 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this Phase 1 study is to assess the safety and efficacy of single treatment of AGN-151586 and of OnabotulinumtoxinA in the glabellar complex of participants with moderate to severe glabellar lines (GL).

Conditions

  • Glabellar Lines

Interventions

  • AGN-151586Drug

    Intramuscular injection

  • OnabotulinumtoxinADrug

    Intramuscular injection

  • PlaceboDrug

    Intramuscular injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Adverse Events (AEs)Time frame: Up to approximately 10.4 months
  2. Number of Participants with the Presence of Binding and Neutralizing Antidrug Antibodies to AGN-151586 and/or OnabotulinumtoxinATime frame: Up to approximately 10.4 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Investigate MD /ID# 270771

    Scottsdale, Arizona

  • Eye Research Foundation /ID# 270827

    Newport Beach, California

  • Marcus Facial Plastic Surgery /ID# 270770

    Redondo Beach, California

  • Skin Research Institute LLC /ID# 270831

    Coral Gables, Florida

  • Skincare Physicians /ID# 271018

    Chestnut Hill, Massachusetts

  • Wilmington Dermatology Center /ID# 270828

    Wilmington, North Carolina

  • Austin Institute for Clinical Research - Pflugerville /ID# 270834

    Pflugerville, Texas

  • SkinDC /ID# 270932

    Arlington, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.